Amphastar Pharmaceuticals (AMPH) EBITDA Margin Growth (3y) (2016 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) EBITDA Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | 1,129.00 |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | -925.00 |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | -2,128.00 |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 293.00 |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | 693.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -230,408.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 457.00 |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | -372.00 |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | 15,005.00 |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -372.00 |
| Mar 31, 2026 | -1,591.00 |
| Dec 31, 2025 | -857.00 |
| Sep 30, 2025 | -614.00 |
| Jun 30, 2025 | 408.00 |
| Mar 31, 2025 | 391.00 |
| Dec 31, 2024 | 414.00 |
| Sep 30, 2024 | 776.00 |
| Jun 30, 2024 | 1,989.00 |
| Mar 31, 2024 | 1,794.00 |
| Dec 31, 2023 | 2,731.00 |
| Sep 30, 2023 | 3,604.00 |
| Jun 30, 2023 | 2,873.00 |
| Mar 31, 2023 | 1,504.00 |
| Dec 31, 2022 | 2,831.00 |
| Sep 30, 2022 | 1,634.00 |
| Jun 30, 2022 | 1,887.00 |
| Mar 31, 2022 | 2,193.00 |
| Dec 31, 2021 | 1,834.00 |
| Sep 30, 2021 | 1,870.00 |